Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer
Amanda F. Baker(Roche (United States)), Setsuko K. Chambers(University of Arizona), Cynthia Laughren(University of Arizona), Mary C. Clouser(University of Arizona), Heather Wright(University of Arizona), David S. Alberts(University of Arizona), Denise J. Roe(University of Arizona), Janice L. Cohen(University of Arizona), Haiyan Cui(Tongji University)
Cited by 0
Related Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns
|Alimentary Pharmacology & Therapeutics|2003|396
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383